Last reviewed · How we verify
NCT05524415
Evaluation of Neurosteer System in Stroke Patients
trial testing Neurosteer EEG recorder in Acute Stroke. Withdrawn.
31 December 2023
Quick facts
| Lead sponsor | Neurosteer Ltd. |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 1 January 2023 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Neurosteer EEG recorder
Conditions studied
- Acute Stroke — all drugs for Acute Stroke →
Sponsor
Neurosteer Ltd.
Who can join
18 and older, any sex, with Acute Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an observational study. Patients who fulfill all inclusion criteria and none of the exclusion criteria will be enrolled in the study, be neurologically evaluated and will go through a series of EEG recordings during their hospitalization. EEG recordings will be analyzed using proprietary computational analyses.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05524415
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Neurosteer EEG recorder
Trials testing the same drug.
- NCT05528445 — Evaluation of Cognitive State in Seniors Using Neurosteer EEG System · completed
Other recruiting trials for Acute Stroke
Currently open trials in the same condition.
- NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
- NCT07295366 — Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Cont · Phase 4 · recruiting
- NCT07355881 — mSOAR and Early Mortality in Acute Stroke · recruiting
- NCT07301372 — Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemi · Phase 4 · recruiting
- NCT07167550 — The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke · Phase 3 · recruiting
Other Neurosteer Ltd. trials
Trials by the same sponsor.
- NCT05528445 — Evaluation of Cognitive State in Seniors Using Neurosteer EEG System · completed
- NCT04683835 — Evaluation of Cognitive State in Senior Subjects Using Neurosteer EEG System · completed
- NCT04386902 — Evaluation of Cognitive State Using Neurosteer EEG System · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05524415 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neurosteer Ltd.
- Last refreshed: 8 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05524415.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing